Jeonjinbio Co. Ltd Cash Flow-to-Debt Ratio
Jeonjinbio Co. Ltd cash flow-to-debt ratio. Jeonjinbio Co. Ltd (110020) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of ₩313.21 Million could theoretically repay 0% of its total liabilities (₩1.27 Billion) in one year. Check cash flow quality index of Jeonjinbio Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Jeonjinbio Co. Ltd (2015–2024)
Cash flow-to-debt ratio of Jeonjinbio Co. Ltd from 2015 to 2024. Historical debt coverage capacity for Jeonjinbio Co. Ltd across 10 annual periods. Check Jeonjinbio Co. Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Jeonjinbio Co. Ltd Cash Flow-to-Debt Ratio by Year (2015–2024)
Jeonjinbio Co. Ltd cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Jeonjinbio Co. Ltd. For the full cash flow conversion analysis, see 110020 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 2.52x | ₩3.01 Billion | ₩1.19 Billion | ▲ +9732.7% |
| 2023 | -0.03x | ₩-300.60 Million | ₩11.48 Billion | ▲ +94.1% |
| 2022 | -0.44x | ₩-3.71 Billion | ₩8.36 Billion | ▼ -161.0% |
| 2021 | -0.17x | ₩-2.38 Billion | ₩14.02 Billion | ▲ +45.4% |
| 2020 | -0.31x | ₩-2.31 Billion | ₩7.41 Billion | ▲ +15.7% |
| 2019 | -0.37x | ₩-1.30 Billion | ₩3.51 Billion | ▲ +45.1% |
| 2018 | -0.67x | ₩-2.16 Billion | ₩3.21 Billion | ▼ -523.8% |
| 2017 | -0.11x | ₩-413.19 Million | ₩3.83 Billion | ▼ -110.6% |
| 2016 | -0.05x | ₩-181.90 Million | ₩3.55 Billion | ▲ +79.1% |
| 2015 | -0.25x | ₩-1.95 Billion | ₩7.95 Billion | — |